Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-22

Clinical Trial Update: Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing alefacept plus narrow-band UV-B phototherapy to alefacept alone in chronic plaque psoriasis completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alefacept (Alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2011-04-22